Trial Profile
OLYMPE - Prospective Cohort Study on the Management of Patients With Relapsed Follicular Lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Acronyms OLYMPE
- Sponsors Roche
- 18 Dec 2014 New trial record